Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Volanesorsen

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1TEGSEDI and WAYLIVRA revenue, net

    02 3Tegsedi and Waylivra Revenue, Net

    03 4Waylivra

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : TEGSEDI and WAYLIVRA revenue, net

    Inotersen, Volanesorsen

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : TEGSEDI and WAYLIVRA revenue, net

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Ionis Pharmaceuticals

    Inotersen, Volanesorsen

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2021 Revenue in Millions : 56

    2020 Revenue in Millions : 70

    Growth (%) : -21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Waylivra

    Inotersen, Volanesorsen

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Waylivra

    Sweden
    arrow
    iPHEX India
    Not Confirmed

    Swedish Orphan Biovitrum AB

    Inotersen, Volanesorsen

    Main Therapeutic Indication : Genetic Disorders

    Currency : USD

    2021 Revenue in Millions : 13

    2020 Revenue in Millions : 0

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Tegsedi and Waylivra Revenue, Net

    Inotersen, Volanesorsen

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Tegsedi and Waylivra Revenue, Net

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Ionis Pharmaceuticals

    Inotersen, Volanesorsen

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2022 Revenue in Millions : 30

    2021 Revenue in Millions : 56

    Growth (%) : -46

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Tegsedi and Waylivra Revenue, Net

    Inotersen, Volanesorsen

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Tegsedi and Waylivra Revenue, Net

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Ionis Pharmaceuticals

    Inotersen, Volanesorsen

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2023 Revenue in Millions : 35

    2022 Revenue in Millions : 30

    Growth (%) : 16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Waylivra

    Inotersen, Volanesorsen

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Waylivra

    Sweden
    arrow
    iPHEX India
    Not Confirmed

    Swedish Orphan Biovitrum AB

    Inotersen, Volanesorsen

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2022 Revenue in Millions : 14

    2021 Revenue in Millions : 13

    Growth (%) : 10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Waylivra

    Inotersen, Volanesorsen

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Waylivra

    Sweden
    arrow
    iPHEX India
    Not Confirmed

    Swedish Orphan Biovitrum AB

    Inotersen, Volanesorsen

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2023 Revenue in Millions : 20

    2022 Revenue in Millions : 14

    Growth (%) : 39

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Tegsedi and Waylivra Revenue, Net

    Inotersen, Volanesorsen

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Tegsedi and Waylivra Revenue, Net

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Ionis Pharmaceuticals

    Inotersen, Volanesorsen

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2024 Revenue in Millions : 34

    2023 Revenue in Millions : 35

    Growth (%) : -2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Waylivra

    Inotersen, Volanesorsen

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Waylivra

    Sweden
    arrow
    iPHEX India
    Not Confirmed

    Swedish Orphan Biovitrum AB

    Inotersen, Volanesorsen

    Main Therapeutic Indication : Genetic Diseases

    Currency : USD

    2024 Revenue in Millions : 27

    2023 Revenue in Millions : 20

    Growth (%) : 34

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF